Home > Insider Trading > Filing (0001055726-19-000046)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1055726	Inovio Pharmaceuticals Inc.	INO	Surgical & Medical Instruments & Apparatus (3841)	330969592

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1464549	Joseph Jong Kim	660 W. Germantown Pike Suite 110 Plymouth Meeting PA 19462	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-05-31	500,000	$2.44	1,911,055	No	4	S	Direct
Common Stock	Disposition	2019-06-03	832,848	$2.30	1,078,207	No	4	S	Direct
Common Stock	Disposition	2019-05-31	500,000	$2.40	1,113,232	No	4	S	Indirect	By Family Limited Partnership
Common Stock	Disposition	2019-06-03	296,705	$2.31	816,527	No	4	S	Indirect	By Family Limited Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By Family Limited Partnership
No	4	S	Indirect	By Family Limited Partnership

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	33,563	Indirect	By Daughter: EK
Common Stock	33,775	Indirect	By Son: JK1
Common Stock	5,975	Indirect	By Spouse
Common Stock	33,533	Indirect	By Son: JK2

Footnotes

The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan.
These transactions were executed in multiple trades at prices ranging from $2.36 to $2.76, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These transactions were executed in multiple trades at prices ranging from $2.15 to $2.41, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These transactions were executed in multiple trades at prices ranging from $2.17 to $2.42, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.